Home Tags OAG 023 – July 2019
OAG 023 – July 2019 Related Content
Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.
Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.
ECR design and develop smart solutions supporting transport operators across the globe. With unique hardware in the form of compact, all in one solutions, we help customers to ensure that every ticketing experience is seamless, reliable and easy.
Dr Kim Hammond-Kosack at Rothamsted Research highlights an aspect of plant pathology that concerns the importance of finding new ways to disarm old enemies in wheat diseases.
Maintaining an up-to-date end-user device environment has been a challenge for many, but it does not need to be, Sam Newman, Technical Director of OGEL IT LTD explains.
Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Dr Diana W. Bianchi, Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), exposes the need to address maternal mortality.
Editor of Open Access Government, Jonathan Miles, spoke to Juan Meza at the National Science Foundation about the launch of four new centres to bring mathematical perspectives to the biological search for the Rules of Life.
In this article, Paul Bomke and Lena Kuntz discuss counselling centres in Germany, particularly in the Palatinate region.
Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
In this second interview, Professor Dr Martin Flück reveals how his research aims to shed light on the mechanisms that govern skeletal muscle function in health and disease, with the goal of translating the findings into more effective clinical applications.
At the Alexanderson Institute in Sweden, new and exciting methods are created to promote future growth, as we now discover.
Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA) examines the future of hemp and explains in this vein, what is at stake, as well as looking back at its fascinating history.
Jen-Yuan (James) Chang, Professor at the Department of Power Mechanical Engineering at the National Tsing Hua University, Taiwan, tells us why the Adaptive Robotic Gripper is the route to grasp the wave of Industrial 4.0 and smart manufacturing.
Beth Perry, Catherine Durose and Liz Richardson reflect on the findings of the Jam and Justice Action Research Collective in Greater Manchester and discuss how social innovation can support citizen participation.
Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.
Dominik Littfass, HELCOM Communication Secretary explains the biofouling – the attachment of living organisms to the hull of ships – one of the main vectors of invasions of aquatic ecosystems from alien or non-indigenous species.
Cllr Peter Box, Leader of Wakefield Council and Chair, Key Cities Group explains how Britain’s town and city centres face significant challenges in redefining their purpose for local residents, visitors and businesses.
Jenny Hirst MBE, Co-Chair, highlights the charitable work involved at InDependent Diabetes Trust to support people living with diabetes in the UK.
José Inácio Faria MEP, Group of the European People’s Party (Christian Democrats) explains the approach of taking advantage of the EU scale to improve national healthcare systems.